Please Wait...

Congressman Patrick Meehan Visits Bioclinica

Congressman Meehan and Bioclinica CEO John Hubbard at recent visit to Bioclinica's Audubon offices

Bioclinica was honored to host Congressman Patrick Meehan representing the 7th Congressional District in Pennsylvania in a visit to our Audubon, Pennsylvania offices on August 28. Congressman Meehan met with Bioclinica senior leadership, including our CEO Dr. John Hubbard, who is the 2017 Chairman of the Association of Clinical Research Organizations (ACRO), joined by ACRO Executive Director Douglas Peddicord. The discussion provided a view into the biopharma industry and Bioclinica’s role in advancing drug development by employing an approach that combines science and technology.

 

 

Congressman Patrick Meehan visits with Bioclinica staff joined by ACRO Executive Director Douglas Peddicord

During his visit, Congressman Meehan also participated in a town hall gathering with staff, many of whom reside within his district covering parts of southeastern Pennsylvania. "The life sciences industry is making a significant economic impact in our region as well as important contributions globally in people's health," said Congressman Meehan. "I appreciate this opportunity to see Bioclinica's operation, innovation, and remarkable work you do in bringing new cures to people in need."

 

 

Congressman Meehan hears from Bioclinica CEO John Hubbard, PhD and other company executives about Bioclinica's contributions, leading to new cures

Dr. Hubbard recognized Congressman Meehan's ongoing support of the biopharma industry and representation on Capitol Hill saying, "We appreciate all you do in support of our challenges and opportunities in the development of new cures." One such effort was the introduction of the Domestic Research Enhancement Act of 2017 with co-sponsors Rep George Holding and G.K. Butterfield of North Carolina. The Act modernizes the research and development tax credit to recognize the essential role contract research plays in the development of new pharmaceuticals, biologics, and medical devices.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

RT @SchulmanIRB: #FDA final rule requires #medicaldevice #research conducted outside US to conform with GCP standards | via @RAPSorg https:…
bioclinica (14 hours ago)
RT @manchempharma: Paul Brooks, Executive Director, @RAPSorg comments on Brexit and the operational trade and regulatory environment affect…
bioclinica (14 hours ago)
RT @eClinical_Jen: Clinical Data Management articles available on SCDM Website - While all articles are available to members, there are sel…
bioclinica (14 hours ago)
Live from Las Vegas where Bioclinica's Research Development Director Marieke Cajal, PhD, is presenting on site star… https://t.co/lVglg6NWdV
bioclinica (15 hours ago)
Many thanks all who attended @bioclinica's Executive Roundtable on Safety Mgmt for Pharma Cos in Japan in Tokyo th… https://t.co/OzHeSvHTUk
bioclinica (15 hours ago)
RT @bioclinica: @CardiacSafety Consortium needs your feedback! Help make the upcoming think tank "Evaluation of #MobileTechnologies in #CV…
bioclinica (17 hours ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen